About
Karin is a globally experienced science and business executive with more than 20 years of diverse experience in biotech drug discovery, platform technologies, cell/gene therapy and medical device companies. Her career spans the Boston area, Silicon Valley and the Cambridge cluster. She was an early employee in several successful start-ups where she made significant contributions to rapid growth of companies to IPO and beyond through fostering scientific innovation, managing scale-up and providing strategic leadership. Karin combines commercial accomplishments with strong scientific leadership.
Highlights
- Chief Operating officer at Mursla Ltd, a diagnostics company focused on providing early detection tests for several significant cancers
- Previously Chief Business Officer at Mogrify Ltd, transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies
- Executive Director at StemBond Technologies
- Participates in several initiatives to foster innovation in the Cambridge ecosystem, mentor to several start-up companies
Contact us
Let's get in touch
info@namiercapital.com167 Fleet Street, London, EC4A 2EA, United Kingdom